1. Home
  2. ETON vs KOSS Comparison

ETON vs KOSS Comparison

Compare ETON & KOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eton Pharmaceuticals Inc.

ETON

Eton Pharmaceuticals Inc.

HOLD

Current Price

$15.87

Market Cap

498.8M

Sector

Health Care

ML Signal

HOLD

Logo Koss Corporation

KOSS

Koss Corporation

HOLD

Current Price

$4.56

Market Cap

43.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ETON
KOSS
Founded
2017
1953
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Consumer Electronics/Appliances
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
498.8M
43.6M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
ETON
KOSS
Price
$15.87
$4.56
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$29.67
N/A
AVG Volume (30 Days)
277.8K
23.6K
Earning Date
11-06-2025
01-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$70,316,000.00
$13,493,080.00
Revenue This Year
$113.27
N/A
Revenue Next Year
$36.70
N/A
P/E Ratio
N/A
N/A
Revenue Growth
102.77
11.58
52 Week Low
$11.09
$4.00
52 Week High
$23.00
$8.59

Technical Indicators

Market Signals
Indicator
ETON
KOSS
Relative Strength Index (RSI) 40.84 42.73
Support Level $16.13 $4.56
Resistance Level $17.19 $4.86
Average True Range (ATR) 0.75 0.19
MACD 0.10 -0.01
Stochastic Oscillator 29.84 12.50

Price Performance

Historical Comparison
ETON
KOSS

About ETON Eton Pharmaceuticals Inc.

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.

About KOSS Koss Corporation

Koss Corp is engaged in the design, manufacture, and sale of stereo headphones and related accessory products. It operates in the audio/video industry segment of the home entertainment industry. The company markets a line of headphones, wireless Bluetooth headphones, wireless Bluetooth speakers, computer headsets, telecommunications headsets, and active noise-canceling headphones. The majority of the firm's revenue is derived from sales of stereo headphones. The Company also sells products to distributors for resale to school systems, and directly to other manufacturers for inclusion with their own products.

Share on Social Networks: